Introduction
The lung has evolved a variety of mechanisms to deal with microorganisms that evade the defenses of the upper airways and are deposited on the respiratory epithelial surface (1) . After the first-line innate immune defenses such as the mucous barrier, mucociliary activity, and locally produced peptide antibiotics (2, 3) , the next line of defense is the phagocyte system, including alveolar macrophages resident on the epithelial surface and neutrophils recruited to the lung (4, 5) . Phagocytes can ingest microorganisms directly or after they are coated with surfactant proteins or complement, but the most efficient mechanism of phagocytosis is the ingestion of IgG-coated microorganisms via IgG Fc receptors (Fcγ receptors) on the phagocyte surface (6) . The interaction of these receptors with their cognate IgG complexed to a microorganism leads to rapid engulfment and destruction of the opsonized targets. There are 3 classes of Fcγ receptors (FcγR): FcγRI (CD64), FcγRII (CD32), and FcγRIII (CD16) (7) (8) (9) (10) (11) (12) (13) . The FcγRs are encoded by at least 8 genes, and, together with alternative mRNA splicing, the result is a broad diversity of FcγR isoforms. Each Fcγ receptor is composed of a chain containing the ligand-binding site, and some Fcγ receptors (FcγRIA, FcγRIIIA) are expressed as a multisubunit receptor complex in association with a non-IgG-binding subunit (γ and/or ζ) (7) (8) (9) (10) (11) (12) (13) .
The identification and characterization of the FcγR (7-13) and the development of strategies to transfer and express exogenous genes in the airway epithelium (14) (15) (16) (17) has led us to hypothesize that transient transfer and expression of FcγR in the airway epithelium might enable the epithelium to bind and ingest opsonized microorganisms, and thus provide an additional pulmonary host defense strategy against infectious agents. To evaluate this concept, we have used a replication-deficient adenovirus (Ad) vector to transfer human FcγRIIA cDNA to the airway epithelium of experimental animals. We then challenged the animals with an intratracheal burden of Pseudomonas aeruginosa. The data demonstrate that the strategy of transiently enabling the epithelium to phagocytize Pseudomonas can provide a new level of Fcγ receptors on the surface of phagocytic cells bind the Fc region of IgG and mediate binding, phagocytosis, and destruction of particulate antigens opsonized by the antigen-specific IgG molecule. The present study evaluates the feasibility of converting lung epithelial cells into phagocytic cells using adenovirus (Ad) vector-mediated gene transfer of FcγRIIA cDNA to induce expression of the human FcγRIIA receptor. Binding and phagocytosis of opsonized sheep red blood cells (SRBCs) by the A549 human lung epithelial cell line after Ad-mediated FcγRIIA gene transfer was demonstrated using light and fluorescence microscopy and phagocytic assays with 51 Cr-labeled SRBCs. When A549 cells were infected with an Ad vector expressing a FcγRIIA mutant in which 2 of 3 cytoplasmic tyrosines have been replaced with phenylalanine, only binding, but not phagocytosis, of opsonized SRBCs was observed. In vivo expression of FcγRIIA in the lung after intratracheal administration of the AdFcγRIIA enhanced clearance of opsonized Pseudomonas aeruginosa from the lung in normal rats and in mice deficient in Fcγ receptor expression. Similar results were observed with a chimeric FcγRIIA construct containing the extracellular domain of FcγRIIIA. Together, these data demonstrate that Ad-mediated FcγRIIA receptor cDNA expression can mediate the binding and phagocytosis of opsonized particulate antigens by normally nonphagocytic cells, suggesting that gene-transfer strategies might be used to utilize nonphagocytic cells to clear bacteria or other opsonized particulate antigens from the respiratory tract.
host defense that may be useful in helping to reduce the burden of an infectious agent in the lung.
Methods
Adenovirus vectors. The replication-deficient recombinant Ad vectors AdFcγRIIA, AdFcγRIIA mutant, and AdNull are all E1a, partial E1b, and partial E3 vectors based on adenovirus type 5 (Ad5), in which an expression cassette containing a promoter driving the expression of a recombinant gene is inserted at the site of the E1 deletion (15) . The AdFcγRIIA vector contains an expression cassette of the cytomegalovirus early/intermediate promoter/enhancer followed by an artificial splice, the human FcγRIIA cDNA (18, 19) , and the SV-40 stop/poly(A) signal (20) . The AdFcγRIIA mutant vector is similar but contains a mutated human FcγRIIA cDNA in which 2 of 3 cytoplasmic tyrosines (Y282 and Y298) (19, 21) have been replaced with phenylalanine, rendering the receptor unable to deliver appropriate intracellular signals and thus able to bind an opsonized antigen, but unable to signal the cell to ingest the antibody-antigen complex. AdNull is identical, except that it lacks a gene in the expression cassette (20) . AdFcγRIIIA is a new FcγRIIA construct containing the extracellular domain of FcγRIIIA and the transmembrane and cytoplasmic domains of FcγRIIA. This FcγRIIA construct enables detection of the IgG-coated bacteria by the extracellular domain of FcγRIIIA, and similar chimeric Fcγ receptors function efficiently in inducing phagocytosis in epithelial cells (22, 23) . The Ad vectors were propagated, purified, and stored at -70°C as described previously (14, 15) . Titers of viral preparations were determined by plaque assay using 293 cells (24) . All preparations were free of replication-competent Ad (17) .
Expression of FcγRIIA in A549 cells. A549 cells, a lung epithelial cell line derived from a human lung carcinoma, were obtained from American Type Culture Collection (CCL-185; Manassas, Virginia, USA) and grown on 6-well tissue culture plates (Becton Dickinson Labware, Franklin Lanes, New Jersey, USA) in F-12K Nutrient Mixture (Kaighn's Modification; GIBCO BRL, Gaithersburg, Maryland, USA) with 10% FBS (GIBCO BRL), glutamine (2 mM; Biofluids Inc., Rockville, Maryland, USA), penicillin G (50 U/mL; GIBCO BRL) and streptomycin (50 µL/mL; GIBCO BRL).
To assess expression of the FcγRIIA mRNA in vitro, A549 cells were infected with AdFcγRIIA at 1 and 10 moi, using noninfected cells as controls. Total RNA was extracted (RNA Extraction Kit; CLONTECH Laboratories Inc., Palo Alto, California, USA) and transferred (10 µg/lane) to nylon membranes after electrophoretic separation through a 1% agarose gel. The membranes were hybridized using a human FcγRIIA cDNA probe labeled with [ 32 P]dCTP (Random Primer Labeling Kit; Stratagene, La Jolla, California, USA) for 2 hours using standard methods (25) . A 32 P-labeled human GAPDH probe was used as a positive control (26) .
To To observe AdFcγRIIA-induced phagocytosis directly, A549 cells were grown and infected as already described here. The cells were incubated with SRBCs and washed in PBS 3 times, and the SRBCs bound to the cell surface but not internalized were lysed by incubation with hypotonic lysing buffer (31 mM ammonia chloride, 2 mM potassium bicarbonate, 20 µM ethylenediaminotetraacetic acid; all from Sigma Chemical Co.) for 60 seconds. The cells were then fixed in 4% paraformaldehyde and stained by a Giemsa stain. To view cell-associated SRBCs, 4 unstained cultures were treated with 1% alcoholic eosin (EM Science, Hawthorne, New York, USA) for 30 seconds, rinsed 3 times in PBS (pH 7.4; Biofluids Inc.), and mounted with 10% glycerol using glass coverslips. Cells were viewed using a Nikon Microphot SA microscope equipped with a ×40 PlanApo objective, 100 W mercury arc, and a Nikon Texas red filter set (both from Nikon Inc., Melville, New York, USA). Before capturing images, samples were exposed to epifluorescence illumination for 30 seconds to bleach background eosin staining and to expose eosin-stained SRBCs.
The function of the FcγRIIA protein expressed by A549 cells after Ad-mediated gene transfer was determined in vitro by quantification of binding and phagocytosis of IgGopsonized 51 Cr-labeled SRBCs. The A549 cell/SRBC ratio for all incubations was 1:500. A549 cells (5 × 10 5 per well) were infected with AdFcγRIIA at 10 moi, using AdFcγRIIA mutant-and AdNull-infected cells, and noninfected cells as controls. After 48 hours, the cells were incubated for 60 minutes with an IgG rabbit anti-SRBC antibody-coated (Accurate Chemical & Scientific Corp.), 51 Cr-labeled (Du Pont NEN Research Products, Boston, Massachusetts, USA) SRBCs (Accurate Chemical & Scientific Corp.). Nonopsonized, 51 Cr-labeled SRBCs were used as controls. To evaluate binding of IgG- 51 Cr-labeled SRBCs to the FcγRIIA cDNA-modified cells, the A549 cells were washed 3 times in PBS and then lysed by incubation in 0.5% SDS solution (Sigma Chemical Co.) for 10 minutes on ice (28) . To evaluate phagocytosis, A549 cells were incubated with IgG- 51 Cr-labeled SRBCs for 60 minutes, washed 3 times in PBS, incubated for 60 seconds in hypotonic lysing buffer to lyse bound noninternalized SRBCs, and then lysed in 0.5% SDS for 10 minutes on ice. The radioactivity of the lysate was measured using a gamma counter.
To evaluate internalization of opsonized bacteria, A549 cells were infected with AdFcyRIIA, AdFcyRIIA mutant, or AdNull. Forty-eight hours later, the cells were infected with 3 CFU/cell of opsonized P. aeruginosa (PAO1 nonmucoid laboratory strain) (29) . The bacteria were grown at 37°C in tryptic soy broth (Difco Laboratories, Detroit, Michigan, USA) to the midlog phase, washed in PBS, and opsonized by incubation for 30 minutes with rabbit anti-PAO1 polyclonal antibody (1:200 dilution) at 37°C. After 30 minutes, the cells were washed and lysed with 0.5% Triton X-100 (Sigma Chemical Co.), and the bacterial counts were determined by 18-hour cultures of serial dilutions at 37°C on 1.5% MacConkey agarose (Difco Laboratories) plates. To evaluate bacterial clearance by other lung cell lines, the human lung epithelial cell lines HS 24 or BET-1A, infected with AdFcγRIIA, were infected with opsonized Pseudomonas or Staphylococcus aureus for 60 minutes, and the number of bacteria was determined by culturing the bacteria from the supernatant.
In vivo expression of FcγRIIA. To evaluate expression of the FcγRIIA cDNA in vivo, female Sprague-Dawley rats (250-300 g; Taconic Farms, Germantown, New York, USA) were anesthetized with intramuscular injection of ketamine (60 mg/kg; Fort Dodge Lab Inc., Fort Dodge, Iowa, USA) and xylazine (5 mg/kg; Buttler Co., Columbus, Ohio, USA). The Ad vectors (AdFcγRIIA or AdNull) were administered intratracheally (10 9 plaque-forming units [PFU] in 100 µL 0.9% NaCl). Naive animals were used as controls. Forty-eight hours after administration, the animals were sacrificed (pentobarbital overdose intraperitoneally) and the lungs were removed. Total RNA was extracted (RNA Extraction Kit) and transferred (10 µg/lane) to nylon membranes after electrophoretic separation through a 1% agarose gel. The membranes were hybridized using a human FcγRIIA cDNA probe labeled with [ 32 P]dCTP (Random Primer Labeling Kit) for 2 hours using standard methods (25) . A 32 P-labeled human GAPDH probe was used as a positive control (26) . To analyze the tissue expression and distribution of FcγRIIA in the lungs of the animals, the lungs of the infected animals were harvested 48 hours after administration of AdFcγRIIA or AdNull, as were those of uninfected animals. The lungs were inflated with 4% paraformaldehyde, fixed for 24 hours, and then transferred to 70% ethanol. Immunohistochemical staining for the FcγRII was done on 5-mm sections using the antiFcγRII antibody IV.3 (Medarex Inc.); an IgG2b-matched antibody was used as control.
Clearance of P. aeruginosa from the lung. To assess the clearance of P. aeruginosa from the lung after Ad-mediated transfer of FcγRIIA or FcγRIIIA cDNA, these adenoviral constructs or, as a control, either AdNull or no Ad (naive controls), was administered intratracheally (10 9 PFU in 100 µL 0.9% NaCl) to anesthetized female Sprague-Dawley rats (250-300 g). Forty-eight hours later, the animals were infected intratracheally with 2 × 10 8 CFU of opsonized P. aeruginosa (PAO1 nonmucoid laboratory strain) (29) . The opsonized bacteria were prepared as has already been described for the in vitro experiments. The bacteria were grown at 37°C in tryptic soy broth to the midlog phase, washed in PBS, and opsonized by incubation for 30 minutes with rabbit anti-PAO1 polyclonal antibody (1:200 dilution) at 37°C. After 20 hours, the animals were sacrificed; the lungs were removed, weighed, homogenized in 0.9% NaCl; and then the homogenate was incubated on ice for 20 minutes with 0.5% Triton X-100 to release intracellular bacteria (30) . Bacterial counts were determined by 18-hour cultures of serial dilutions at 37°C on 1.5% MacConkey agarose plates and were expressed as CFU per gram of lung tissue. The number of bacteria reflects the total number present in the lung at the time of sacrifice.
As another measure of the ability of AdFcγRIIA gene transfer to inhibit the growth of bacteria from the lung, the experiments were performed in mice deficient in the Fcγ receptor γ subunit (31) . These immunocompromised animals do not express FcγRI and FcγRIII in phagocytic cells, and they lack the capacity to phagocytize antibodycoated particles (31, 32) . Animals (6-8 weeks old) were anesthetized with intramuscular injection of ketamine (200 mg/kg) and xylazine (10 mg/kg). The Ad vectors (AdFcγRIIA or AdNull) were administered intratracheally (10 9 PFU in 100 µL 0.9% NaCl). After 48 hours, animals were infected intranasally with 4 × 10 7 CFU of P. aeruginosa (PAO1 strain) opsonized with polyclonal rabbit anti-PAO1 antibody as already described here. After 20 hours, the animals were sacrificed, the lung was removed, and bacterial counts were determined as already described.
Statistical evaluation. The results are expressed as mean ± SEM. Statistical comparisons were made using the unpaired 2-tailed Student's t test. Evaluation of the function of the FcγRIIA expressed in the lung after intratracheal administration of the AdFcγRIIA vector demonstrated that Ad-mediated FcγRIIA cDNA gene transfer in vivo enhances clearance of opsonized bacteria from the lung of experimental animals over a 20-hour period ( Figure 6 ). In this regard, rats infected with AdFcγRIIA or AdFγRIIIA cleared bacteria from the lung more efficiently than did animals infected with the AdNull control vector or naive animals (Figure 6a ; P < 0.02 AdFcγRIIA and AdFcγRIIIA compared with AdNull and controls). There was no significant difference between the AdNull-infected ani-mals compared with the controls (P > 0.1), although the number of bacteria in the AdNull-infected animals was slightly decreased compared with the controls. Likewise, clearance of bacteria in the Fcγ receptor γ subunit-knockout mice was also enhanced in animals infected with AdFcγRIIA compared with animals infected with AdNull (Figure 6b ; P < 0.03). All animals survived the challenge with the opsonized bacteria for the period observed.
Results

AdFcγRIIA expression in A549 cells. Several lines of evidence
demonstrated that Ad-mediated FcγRIIA cDNA gene transfer results in expression of the FcγRIIA cDNA in the normally nonphagocytic A549 cells. To evaluate the ability
Discussion
Expression of Fcγ receptors on the surface of phagocytic cells conveys to the cells the ability to recognize, bind, and internalize IgG-opsonized particulate antigens and immune complexes (7) (8) (9) (10) (11) (12) (13) . The present study demonstrates the ability of Ad-mediated Fcγ receptor cDNA gene transfer to genetically modify normally nonphagocytic lung epithelial cells to functional phagocytic cells capable of enhancing host defense against a bacterial challenge. In this context, in vitro infection of a lung epithelial cell line with the AdFcγRIIA gene transfer vector resulted in expression of FcγRIIA mRNA and expression of functional FcγRIIA protein on the cell surface, enabling normally nonphagocytic cells to bind and internalize IgG-opsonized SRBCs. Importantly, in vivo intratracheal administration of the AdFcγRIIA gene transfer vector or the AdFcγRIIIA/FcγRIIA chimeric gene transfer vector resulted in expression of the Fcγ receptor cDNA in the lung of experimental animals and enhanced clearance of opsonized P. aeruginosa from the lungs after intratracheal challenge.
Fcγ receptors. The Fc domain of antibodies binds to specialized cell-surface Fc receptors (FcR) (7-13). These Fc receptors are defined by their specificity for immunoglobulin isotypes. Fcγ receptors (IgG-specific Fc receptors) are membrane glycoproteins with extracellular domains related to a C2-set of immunoglobulin related domains, a single membrane-spanning domain, and an intracytoplasmic domain of variable length (33) . Three subclasses of Fcγ receptors have been identified: FcγRI (CD 64), FcγRII (CD 32), and FcγRIII (CD16) (7) (8) (9) (10) (11) (12) (13) . FcγRIIA is the only allotype of Fcγ receptors that efficiently recognizes IgG2 (7) (8) (9) (10) (11) (12) (13) , an IgG isoform that plays an important role in the defense against infection with bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, and P. aeruginosa (34) (35) (36) , and that can directly mediate a phagocytic signal in the absence of an accessory chain or in the absence of other Fcγ receptors (19, 37) . FcγRIIA exists in 2 allelic forms that differ in amino acid at position 131 (arginine R131/histidine H131) in the second immunoglobulin-like domain (38, 39) . This genetic polymorphism is common, with 25% of Caucasians being homozygous for R131/R131 (39) . Interestingly, polymorphisms at this site influence the binding of IgG2 to FcγRIIA, with individuals homozygous for R131/R131 unable to bind IgG2-opsonized bacteria efficiently. Consistent with this in vitro observation, these individuals have a higher incidence of infections with encapsulated bacteria and have an increased mortality when infected with encapsulated bacteria (35, 36) .
Transfer and expression of FcγRIIA to nonphagocytic cells. Using transfection with recombinant plasmids, various Fcγ receptors have been expressed on nonphagocytic cell lines, such as COS-1, Jurkat T-cells, and fibroblasts (19, 37, 40) . These in vitro experiments suggested the possibility that the ectopic expression of a functional phagocytic receptor on the surface of normally nonphagocytic cells would enable these cells to interact with IgGopsonized cells or complexes in a fashion similar to that normally carried out by traditional phagocytes.
In the present study, expression of FcγRIIA in normally nonphagocytic epithelial cells was achieved using a recombinant, replication-deficient Ad vector. Binding and phagocytosis of IgG-opsonized SRBCs by the normally nonphagocytic A549 human lung epithelial cell line were observed after infection with AdFcγRIIA. In contrast, infection with AdFcγRIIA mutant (lacking a functional intracytoplasmic domain) induced only binding, but not phagocytosis, of IgG-opsonized SRBCs. Binding and phagocytosis were not observed by naive cells and cells infected with AdNull, although there were some minor changes within AdNull-infected cells, compared with controls, on binding of nonopsonized and opsonized red cells. These changes were significantly less than those observed with AdFcγRIIA and probably are due to effects of the Ad vector per se on cellular processes as has been observed in other systems (41) . Furthermore, in vitro infection of lung epithelial cells with AdFcγRIIA led to increased uptake of Pseudomonas or S. aureus. In vivo administration to the respiratory epithelial surface of the AdFcγRIIA vector, but not the control
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The AdNull vector, was associated with expression of FcγRIIA mRNA transcripts in the lung. There is overwhelming evidence that in vivo administration of Ad vectors to the respiratory epithelium is associated with expression of the transgene carried by the vector exclusively in the respiratory epithelium (15, 16, 42) . Consistent with these reports, the present study demonstrates expression of FcγRIIA in the lung parenchymal cells after intratracheal administration of AdFcγRIIA. P. aeruginosa and airway inflammation. P. aeruginosa is a ubiquitous, Gram-negative aerobic rod with polar, monotrichous flagella and protein structures on the surface (pili) that are responsible for adherence to respiratory epithelium (43) . Pseudomonas rarely causes infection in the normal host, but as an efficient opportunistic pathogen, it is commonly isolated during nosocomial infections in immunocompromised individuals (44) and is a major pathogen in individuals with cystic fibrosis (45) .
In the present study, enhanced clearance of opsonized P. aeruginosa from the lungs of experimental animals was observed after intratracheal administration of AdFcγRIIA or an AdFcγRIIIA/FcγRIIA chimeric receptor in comparison with naive controls or AdNull-infected (no transgene) animals. The small decrease in the number of bacteria present in the animals infected with AdNull compared with naive controls was not significant and is potentially a reflection of inflammation induced by the Ad vector per se. Similarly, Ad-mediated transfer of FcγRIIA cDNA to the lungs of Fcγ receptor γ chain-knockout mice (31, 32) led to increased clearance of Pseudomonas. Based on the in vitro observations in the lung epithelial cell line, the mechanism by which the AdFcγRIIA vector conveys enhanced clearance of opsonized Pseudomonas to the lung in normal rats and in the Fcγ receptor γ chain-knockout mice is likely due to the internalization and inhibition of bacterial growth caused by the enhanced expression of FcγRIIA on the surface of epithelial cells. It is very unlikely that increased clearance of bacteria is due to efficient gene transfer to professional phagocytic cells, as they are poor targets for Ad-mediated gene transfer and were not different in the FcγRIIA-positive histochemical sections compared with AdNull or uninfected controls (46, 47) . Possible clinical significance. One possible clinical application of this approach may be in the enhancement of bacterial clearance from the airways in individuals with cystic fibrosis. Another application might be in in vivo enhancement of the impaired phagocytosis in diseases such as systemic lupus erythematosus and chronic liver and kidney disease, in which phagocytosis of IgGopsonized bacteria is impaired because of the downregulation of the Fcγ receptors (48) (49) (50) . There are reports of using Ad-mediated gene transfer of either IL-12 and IFN-γ to enhance the clearance of bacteria (51) (52) (53) , and thus, it might be possible to use the combination of more than one gene transfer approach to enhance further the antibacterial defense of the lung and other organs.
Figure 6
Enhanced clearance of P. aeruginosa from the lung after Ad-mediated transfer of FcγRIIA and FcγRIIIA cDNA to the respiratory epithelial surface of experimental animals. (a) Enhanced clearance in normal rats. Sprague-Dawley rats were infected intratracheally with AdFcγRIIA, AdFcγRIIIA, or AdNull (10 9 PFU). After 48 hours, the animals were challenged via the intratracheal route with 10 8 CFU of the PAO1 strain of P. aeruginosa opsonized with rabbit anti-PAO1 polyclonal antibody. After 20 hours, animals were sacrificed, the lungs were removed, and bacterial counts of the lysates were determined. Data are expressed as CFU of PAO1 per gram of lung tissue. Shown are means of CFU per gram lung tissue from naive controls and AdNull-, AdFcγRIIA-, and AdFcγRIIIA-infected animals (n = 5 animals per group). (b) Enhanced clearance in Fcγ receptor-knockout mice. Fcγ receptor-knockout mice were infected intratracheally with AdFcγRIIA or AdNull (10 9 PFU). After 48 hours, the mice were infected intranasally with 4 × 10 7 CFU of the PAO1 strain of P. aeruginosa opsonized with rabbit anti-PAO1 polyclonal antibody. After 20 hours, animals were sacrificed, the lungs were removed, and bacterial counts of the lysates were determined. Data are expressed as CFU of PAO1 per gram of lung tissue. Shown are means of CFU per gram of lung tissue from AdNull-infected animals (n = 7) and AdFcγRIIA-infected animals (n = 10). The data in a and b represent mean ± SEM.
